Novel minicircle vector for gene therapy in murine myocardial infarction

Circulation

Volumn 120, Issue SUPPL. 1, 2009, Pages

  Huang, Mei ^a   Chen, Zhiying ^a   Hu, Shijun ^a   Jia, Fangjun ^a   Li, Zongjin ^a   Hoyt, Grant ^a   Robbins, Robert C ^a   Kay, Mark A ^a   Wu, Joseph C ^a,b,c  

^a Department of Radiology ^*

^b Division of Cardiology   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxia inducible factor; Ischemic heart disease; Minicircle; Molecular imaging

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FIREFLY LUCIFERASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MINICIRCLE DNA; HIF1A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; GENE THERAPY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REPORTER GENE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DNA SUPERCOILING; ESCHERICHIA COLI; GENE VECTOR; GENETICS; METHODOLOGY; PLASMID;

ANIMALS; CELLS, CULTURED; DNA, SUPERHELICAL; ESCHERICHIA COLI; FEMALE; GENE THERAPY; GENETIC VECTORS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MYOCARDIAL INFARCTION; PLASMIDS;

EID: 70349786604     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.841155     Document Type: Article

References (27)

1. Lyon AR, Sato M, Hajjar RJ, Samulski RJ, Harding SE. Gene therapy: targeting the myocardium. Heart. 2008;94:89-99.
2. 2. Marshall E. Gene therapy death prompts review of adenovirus vector. Science. 1999;286:2244-2245. (Pubitemid 30016842)
3. Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2007-an update. J Gene Med. 2007;9:833-842.
4. 4. Jechlinger W. Optimization and delivery of plasmid DNA for vaccination. Exp Rev Vaccines. 2006;5:803-825. (Pubitemid 46021058)
5. 5. Jechlinger W, Azimpour Tabrizi C, Lubitz W, Mayrhofer P. Minicircle DNA immobilized in bacterial ghosts: in vivo production of safe non-viral DNA delivery vehicles. J Mol Microbiol Biotechl. 2004;8: 222-231. (Pubitemid 41368967)
6. 6. Chen ZY, He CY, Meuse L, Kay MA. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther. 2004;11:856-864. (Pubitemid 38714589)
7. Chen Z-Y, He C-Y, Kay MA. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther. 2005; 16: 126-131.
8. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard. V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thorn T, Wilson M, Hong Y. Heart disease and stroke statistics-2008 update: a report from, the Am Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117: e25-e146.
9. 9. Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med. 2003;9:694-701. (Pubitemid 36749218)
10. Yun Z, Lin Q, Giaccia AJ. Adaptive myogenesis under hypoxia. Mol Cell. Biol. 2005;25:3040-3055.
11. 11. Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X, Drukker M, Dylla SJ, Connolly AJ, Chen X, Weissman JL, Gambhir SS, Wu JC. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation. 2006;113:1005-1014. (Pubitemid 43879476)
12. 12. Nemoto S, DeFreitas G, Mann DL, Carabello BA. Effects of changes in. left ventricular contractility on indexes of contractility in mice. Am J Physiol. 2002;283:H2504-H2510. (Pubitemid 35345956)
13. Engel FB, Hsieh PCH, Lee RT, Keating MT. FGFl/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci USA. 2006;103:15546-15551.
14. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor lalpha promoter. Gene Ther. 2001;8:1539-1546.
15. Hiona A, Wu JC. Noninvasive radionuclide imaging of cardiac gene therapy: progress and potential. Nat Clin Pract Cardiovasc Med. 2008; 5(Suppl 2):S87-S95.
16. 16. Wu JC, Chen IY, Wang Y, Tseng JR, Chhabra A, Salek M, Min J-J, Fishbein MC, Crystal R, Gambhir SS. Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium.. Circulation. 2004;110:685-691. (Pubitemid 39056267)
17. 17. Hajjar RJ, Zsebo K, Deckelbaum. L, Thompson C, Rudy J, Yaroshinsky A, Ly H, Kawase Y, Wagner K, Borow K, Jaski B, London B, Greenberg B, Pauly DF, Patten R, Starling R, Mancini D, Jessup M. Design of a phase 1/2 trial of intracoronary administration of AAVl/SERCA2a in patients with heart failure. J Cardiac. Fail. 2008;14:355-367. (Pubitemid 351756538)
18. 18. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Rasko J, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer M Jr, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Eitl HC, High KA, Kay MA. Successful transduction of liver in hemophilia by AAV-Factor JX and limitations imposed by the host immune response. Nat Med. 2006;12:342-347. (Pubitemid 43355084)
19. Wilson J. Humility and clinical trials. MoI Ther. 2007;15:1571-1572.
20. 20. Wu JC, Yla-Herttuala S. Human gene therapy and imaging: cardiology. Eur J Nucl Med Mol Imaging. 2005;32(Suppl 2):S346-S357. (Pubitemid 41796401)
21. 21. Darquet AM, Cameron B, Wils P, Scherman D, Crouzet J. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther. 1997;4:1341-1349. (Pubitemid 28004593)
22. 22. Darquet AM, Rangara R, Kreiss P, Schwartz B, Naimi S, DelaAťe P, Crouzet J, Scherman D. Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther. 1999;6:209-218. (Pubitemid 29089919)
23. 23. Chen Z-Y, Riu E, He C-Y, Xu H, Kay MA. Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol Ther. 2008;16:548-556. (Pubitemid 351314995)
24. Giaccia A, Sum BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Dis. 2003;2:803-811.
25. Kleiman NS, Patel NC, Allen KB, Simons M, Ylä-Herttuala S, Griffin E, Dzau VJ. Evolving revascularization approaches for myocardial ischemia. Am. J Cardiol. 2003;92:9-17N.
26. Huang M, Chan DA, Jia F, Xie X, Li Z, Hoyt G, Robbins RC, Chen X, Giaccia AJ, Wu JC. Short hairpin RNA interference therapy for ischemic heart disease. Circulation. 2008;118:S226-S233.
27. 27. Pislaru S, Janssens SP, Gersh BJ, Simari RD. Defining gene transfer before expecting gene therapy: putting the horse before the cart. Circulation. 2002; 106:631-636. (Pubitemid 34827716)